150 likes | 745 Views
Epidemiology = study of cancer patterns in populations (not on individual basis)Cancer incidence Geographic and environmental factors Age Genetic predisposition to cancer Nonhereditary predisposing conditions1. Cancer incidence 2nd MCC of all the deaths in USAMC cancers in men:Prostate - 3
E N D
1. Neoplasia
2. Epidemiology = study of cancer patterns in populations (not on individual basis)
Cancer incidence
Geographic and environmental factors
Age
Genetic predisposition to cancer
Nonhereditary predisposing conditions
1. Cancer incidence
2nd MCC of all the deaths in USA
MC cancers in men:
Prostate - 33%
Lung - 14.0%
Colon and rectum - 11%
MC cancers in women :
Breast - 25%
Lung -12%
Colon and rectum - 11%
MC cancer causing deaths among both sexes ? LUNG CANCER
3. EpidemiologyIncidence
5. Epidemiology = study of cancer patterns in populations (not on individual basis)
2. Geographic and environmental factors
Geographic
Stomach Cancer – Japan (7-8 times high)
Lung Cancers – USA ( 2 times)
Skin cancers – New Zealand
Environmental
immigration ?Stomach carcinoma of Japanese's immigrants to USA
sun exposure Skin cancers & Ultraviolet rays
Occupational –Asbestos, Vinyl chloride, 2-naphthylamine
Obesity – 52% & 62% ? risk of cancers in Males & Females respectively
Alcohol ? GIT cancers
Cigarette smoking ? Lung cancers
Sexual Practices ? Cervical Cancers
6. Epidemiology Environmental factors
7. Epidemiology = study of cancer patterns in populations (not on individual basis)
3. Age
Incidence of cancers = ?? with age
MC cancer age group = 50 yrs.
MC cancers in Infants & Children - Blastomas
MC cancers in Older Children (± 15 years) =Acute leukemia & CNS neoplasms (2nd MCC of deaths)
4. Genetic predisposition to cancer
MC predisposing factors? Environmental (acquired) + Hereditary (Familial)
Hereditary Predisposition ? 10%
Three categories
Environmental ? proliferations ? possible origins of malignant neoplasms:
Regenerative (Cirrhosis )
Hyperplastic (Endometrial)
Dysplastic ( cervical)
8. Molecular basis of cancer
9. Molecular basis of cancer
1. Fundamental Principles
Non lethal genetic damage =Most important
Monoclonal origin –Leukemia, Lymphoma
Certain regulatory genes are principal
1.Protooncogenes ?growth promoting & normal
Mutations in Proto-oncogene ? Oncogenes (abnormal)
2.Anti-oncogenes (growth-inhibiting/ Tumor-suppressor genes (TSG) =p53 & Rb.
normally suppress cell proliferation.
Mutations of TSG ? release cells from growth suppression & lead to hyper-proliferation.
3.Apoptotic genes (regulate programmed cell death) ?Act as dominant or TS genes
4. Genes regulating damaged DNA
10. Molecular basis of cancer
2. Essential Alterations
Self sufficiency in growth signals? no need of external stimuli
Insensitivity of growth inhibitory signals? TGFß
Evasion of Apoptosis? Ca. cells resistant apoptosis ( inactivation of p53)
Defects in DNA repair ? NER
Limitless replication potential ? telomerase reactivation
Sustained angiogenesis? VEGF
Ability to invade & metastasis ? ?cancer deaths
3. Normal Cell cycle
11. Molecular basis of cancer
3. Normal Cell cycle
Cell-Cycle Checkpoints
Two main checkpoints
1. G1/S transition
S phase ?point of no return
?checks for DNA damage (if yes) ?arrest the cell cycle (??p53)?if damage is not repairable ?apoptotic pathways
2. G2/M
?monitors the completion of DNA replication
?arrest in G2
?important in cells exposed to ionizing radiation? chromosomal abnormalities
G0 stage ?resting (nondividing) cells
Cyclins and cyclin -dependent kinases (CDKs), and inhibitors ? control orderly progression of cells
12. Molecular basis of cancer
3. Normal Cell cycle
Cyclins
?synthesized during specific phases
?activate the CDKs
?decline rapidly
CDKs
?phosphorylating critical target proteins
?cause progression of cells to the next phase of the cell cycle
?bind to cyclins
Cyclin D and RB Phosphorylation
Cyclin D ? first cyclin to increase in the cell cycle (mainly mid G1 )
Cyclin D binds to and activates CDK4 in G1 phase ? cyclin D-CDK4 complex ? Phosphorylation of RB ? ON-OFF switch for the cell cycle
Cell-Cycle Progression beyond the G1/S Restriction Point
Need active complex between cyclin E and CDK2
next decision point ?G2/M transition
Absence of cyclin E ? prevent G0 cells from entering cell cycle
13. Molecular basis of cancer
3. Normal Cell cycle
Cell-Cycle Inhibitors
Function as tumor suppressors
Altered in tumors
1. Cip/Kip ? p21, p27, and p57
?activation of p21 is under the control of p53)
2. INK4/ARF families ? p16INK4a and p14ARF
?block the cell cycle and act as tumor suppressors